(Q46407545)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18199892%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

title

Sex, race, and smoking impact olanzapine exposure (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18199892%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18199892%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Delwyn Miller

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18199892%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

author name string

Kristin L Bigos

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18199892%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Bruce G Pollock

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18199892%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Stephen R Marder

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18199892%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Manickam Aravagiri

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18199892%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Margaret A Kirshner

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18199892%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Lon S Schneider

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18199892%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Robert R Bies

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18199892%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

publication date

1 February 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18199892%20AND%20SRC:MED&resulttype=core&format=json

The Journal of Clinical Pharmacology

1 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18199892%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

volume

48

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18199892%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18199892%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

page(s)

157-165

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18199892%20AND%20SRC:MED&resulttype=core&format=json

Effectiveness of antipsychotic drugs in patients with chronic schizophrenia

1 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0091270007310385

Effectiveness of atypical antipsychotic drugs in patients with Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270007310385

The pharmacokinetic imperative in late-life depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270007310385

Clinical pharmacokinetics of atypical antipsychotics: a critical review of the relationship between plasma concentrations and clinical response

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270007310385

Olanzapine plasma concentrations and clinical response: acute phase results of the North American Olanzapine Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270007310385

Effects of olanzapine plasma concentrations on depressive symptoms in schizophrenia: a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270007310385

Investigation of target plasma concentration-effect relationships for olanzapine in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270007310385

Clinical outcome and olanzapine plasma levels in acute schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270007310385

Population pharmacokinetics in geriatric psychiatry

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270007310385

Olanzapine. Pharmacokinetic and pharmacodynamic profile.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270007310385

Olanzapine pharmacokinetics in pediatric and adolescent inpatients with childhood-onset schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270007310385

Therapeutic drug monitoring of olanzapine: the combined effect of age, gender, smoking, and comedication

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270007310385

The National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) project: schizophrenia trial design and protocol development

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270007310385

Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE): Alzheimer's disease trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270007310385

Estimation of population characteristics of pharmacokinetic parameters from routine clinical data

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270007310385

Role of the smoking-induced cytochrome P450 (CYP)1A2 and polymorphic CYP2D6 in steady-state concentration of olanzapine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270007310385

Smoking impact on CYP1A2 activity in a group of patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270007310385

Stormy weather: race, gene expression, and the science of health disparities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270007310385

Paroxetine: population pharmacokinetic analysis in late-life depression using sparse concentration sampling

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270007310385

CYP2D6 allele frequency in European Caucasians, Asians, Africans and their descendants

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270007310385

Six novel nonsynonymous CYP1A2 gene polymorphisms: catalytic activities of the naturally occurring variant enzymes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270007310385

The distribution of human genetic diversity: a comparison of mitochondrial, autosomal, and Y-chromosome data

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270007310385

Negro, Black, Black African, African Caribbean, African American or what? Labelling African origin populations in the health arena in the 21st century

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270007310385